Loading...

Home
ETF
GENB

GENB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

GENB News

ARK Genomic Revolution ETF Underperforms

3d agoNASDAQ.COM

IPO Market Faces Delays Amid Volatility

5d agorenaissancecapital

Morgan Stanley Begins Coverage of Generate Biomedicines Inc with Overweight Rating and $20 Target Price

Analysts Initiate Coverage on Generate Biomedicines with Strong Upside Potential

6d agoseekingalpha

Key Wall Street Rating Updates from Tuesday

Mar 24 2026CNBC

Cathie Wood Continues to Add to Growth Stock Positions

Mar 03 2026Fool

February IPO Market Review and Outlook

Mar 02 2026renaissancecapital

Generate Biomedicines Announces IPO Terms for $400 Million Raise

Feb 27 2026renaissancecapital

Generate Biomedicines Plans $400 Million IPO Amid February Market Lull

Feb 27 2026renaissancecapital

Generate Biomedicines Raises $400 Million in IPO for AI-Driven Therapies

Feb 27 2026renaissancecapital